Xilio Therapeutics Inc (XLO)

Jun 12, 2026

Xilio Therapeutics Adjusts Board Structure Following Shareholder Votes - TipRanks

Jun 12, 2026

Jun 12, 2026

Daniel Curran reappointed to Class III director at Xilio - TradingView

Jun 12, 2026

Jun 12, 2026

Xilio Therapeutics (XLO) director receives grant of 5,000 stock options - Stock Titan

Jun 12, 2026

Jun 12, 2026

Xilio (XLO) director receives grant of 5,000 stock options at $7.99 - Stock Titan

Jun 12, 2026

Jun 12, 2026

Xilio Therapeutics (XLO) director receives grant of 5,000 stock options at $7.99 - Stock Titan

Jun 12, 2026

Jun 12, 2026

Xilio Therapeutics (XLO) director Xu Yuan receives grant of 5,000 stock options - Stock Titan

Jun 12, 2026

Jun 12, 2026

Xilio Therapeutics (XLO) director receives 5,000 stock options at $7.99 strike - Stock Titan

Jun 12, 2026

Jun 12, 2026

Xilio Therapeutics (XLO) director granted options for 5,000 shares at $7.99 - Stock Titan

Jun 12, 2026

Jun 12, 2026

Board changes and stock plan vote at Xilio Therapeutics (NASDAQ: XLO) - Stock Titan

Jun 12, 2026

Jun 11, 2026

XLO Stock Price, Quote & Chart - ChartMill

Jun 11, 2026

Jun 08, 2026

Top Lunai Bioworks (LNAI) Competitors 2026 - MarketBeat

Jun 08, 2026

Jun 04, 2026

Xilio Therapeutics (XLO) Edges Higher, Testing Resistance After Modest GainsGolden Cross - newsline.com

Jun 04, 2026

Jun 03, 2026

XLO News | XILIO THERAPEUTICS INC (NASDAQ:XLO) - ChartMill

Jun 03, 2026

Jun 01, 2026

Werewolf Therapeutics Stock Stalls While HOWL Holds for Strategic Update - Bez Kabli

Jun 01, 2026

Jun 01, 2026

[EFFECT] Xilio Therapeutics, Inc. SEC Filing - Stock Titan

Jun 01, 2026

May 31, 2026

Xilio Therapeutics Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline AdvancesPreliminary Results - newsline.com

May 31, 2026

May 29, 2026

Xilio Therapeutics (XLO) Holds Near Resistance as Price Action Remains Range-BoundGap Down Bounce Plays - newsline.com

May 29, 2026

May 28, 2026

Xilio Therapeutics (XLO) Shows Resilience with 1.91% Gain, Testing Key ResistanceVWAP Breakout - The Legal Advocate

May 28, 2026

May 27, 2026

Xilio Therapeutics (NASDAQ: XLO) amends shelf to include $14.5M ATM and updated exhibits - Stock Titan

May 27, 2026

May 22, 2026

XLO Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesEarnings Yield Analysis - The Legal Advocate

May 22, 2026

May 21, 2026

Is Xilio Therapeutics (XLO) Still a Buy After +2.89% Rally? 2026-05-21Wyckoff Upthrust - Newser

May 21, 2026

May 19, 2026

Xilio Therapeutics (XLO) Crushes Q1 2026 Estimates — EPS $-0.58 Tops ViewsHigh Interest Stocks - Newser

May 19, 2026

May 18, 2026

Cancer Stocks That Are Advancing the Future of Oncology Care - TradingView

May 18, 2026

May 17, 2026

Xilio Therapeutics, Inc. (XLO) reports Q1 loss, beats revenue estimates - MSN

May 17, 2026

May 17, 2026

Xilio Therapeutics (XLO) Stock Analysis: Falls -5.11%, Watching $7.94 2026-05-17Technical Analysis - Newser

May 17, 2026

May 16, 2026

Xilio Therapeutics (XLO) upgraded to buy: What does it mean for the stock? - MSN

May 16, 2026

May 15, 2026

OrbiMed group discloses stakes in Xilio Therapeutics (NASDAQ: XLO), up to 9.99% - Stock Titan

May 15, 2026

May 15, 2026

Bain Capital entities report 9.99% stake in Xilio Therapeutics (XLO) - Stock Titan

May 15, 2026

May 15, 2026

Point72 (XLO) files 13G/A showing 0% stake in Xilio Therapeutics - Stock Titan

May 15, 2026

May 15, 2026

Sirenia and Alex Silverstein report 9.9% stake in Xilio (NASDAQ: XLO) - Stock Titan

May 15, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 12, 2026

Xilio Therapeutics Releases Q1 2026 Financial Results - AlphaStreet

May 12, 2026

May 12, 2026

Xilio Therapeutics, Inc. 2026 Q1 Quarterly Report: Financials, Risk Factors, and Business Overview - Minichart

May 12, 2026

May 12, 2026

XLO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

May 12, 2026

May 12, 2026

Sagimet Biosciences Releases Q1 2026 Financial Results - AlphaStreet

May 12, 2026

May 12, 2026

Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance

May 12, 2026

May 12, 2026

Xilio Therapeutics Reports Q1 2026 Financial Results, Advances Pipeline with XTX501 IND Filing and AbbVie Milestone Extension - Minichart

May 12, 2026

May 12, 2026

Xilio Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

May 12, 2026

May 12, 2026

According to documents submitted to the U.S. Securities and Exchange Commission (SEC), biotechnology company Xilio Therapeutics Inc. has entered into a common stock sales agreement with investment bank Leerink Partners LLC. - Bitget

May 12, 2026

May 12, 2026

Xilio Therapeutics (NASDAQ: XLO) files $250M shelf, includes $17.22M ATM - Stock Titan

May 12, 2026

May 12, 2026

Xilio Therapeutics, Inc. 1Q 2026: Revenue $12.6M, EPS $(0.58) — 10-Q Summary - TradingView

May 12, 2026

May 12, 2026

Xilio Therapeutics (XLO) boosts Q1 2026 collaboration revenue and extends cash runway into 2028 - Stock Titan

May 12, 2026

May 12, 2026

Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 12, 2026

May 12, 2026

Xilio (Nasdaq: XLO) Q1 2026 loss narrows as cash runway extends to 2028 - Stock Titan

May 12, 2026

May 12, 2026

Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and ... - Caledonian Record

May 12, 2026

May 12, 2026

Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates - GlobeNewswire

May 12, 2026

May 11, 2026

XLO (Xilio Therapeutics) swings to profit, crushing estimates by 147.7 percent as stock gains.Expert Momentum Signals - newser.com

May 11, 2026

May 11, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 7, 2026 - marketscreener.com

May 11, 2026

May 10, 2026

Xilio Therapeutics, Inc. (XLO) Dividend History, Date, and Yield - CoinCodex

May 10, 2026

May 10, 2026

Number of shareholders of Xilio Therapeutics, Inc. – NASDAQ:XLO - TradingView

May 10, 2026

May 08, 2026

XLO Xilio Therapeutics smashes Q4 earnings with 147.7% beat, 589.9% revenue surge, yet shares fall 1.14%.Expert Entry Points - newser.com

May 08, 2026

May 07, 2026

Xilio Therapeutics Grants Options for 146,800 Shares to New Employees - geneonline.com

May 07, 2026

May 07, 2026

New Xilio hire gets stock options for 1,982 shares at $8.32 - Stock Titan

May 07, 2026